Intrance Medical Systems Establishes U S Operations and Names Patrick Shea Chief Executive Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
(0)
Pharmaceutical industry leader to build organization from ground up with commitment to bringing innovation to the advanced Parkinson s disease community
Company plans to initiate U.S. clinical development of its fixed-dose combination treatment for enteral infusion in advanced Parkinson s disease patients
Intrance Medical Systems, Inc., a subsidiary of Sweden-based Intrance Holdings AB, today announced the company has officially established its U.S. operations with the appointment of Patrick M. Shea as Chief Executive Officer and member of the Board of Directors. Mr. Shea will be responsible for building the company s operational and business structure and initiating the U.S. clinical development program for its fixed-dose combination treatment of levodopa, carbidopa and entacapone for enteral infusion in advanced Parkinson s disease patients. The product is currently marketed as Lecigon in the Nordic countries and certain European markets.